BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q4 2025

Type / Class
Equity / Common Shares, $0.001 par value
Symbol
BMEZ on NYSE
Shares outstanding
103,858,423
Price per share
$15.05
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
10,996,937
Total reported value
$158,604,644
% of total 13F portfolios
0%
Share change
+984,541
Value change
+$14,291,091
Number of holders
75
Price from insider filings
$15.05
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Saba Capital Management, L.P. 20% $296,530,547 20,750,913 Saba Capital Management, L.P. 20 Jan 2025

As of 30 Sep 2025, 75 institutional investors reported holding 10,996,937 shares of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ). This represents 11% of the company’s total 103,858,423 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) together control 10% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MORGAN STANLEY 1.7% 1,805,700 +2.3% 0% $26,038,194
BANK OF AMERICA CORP /DE/ 1.5% 1,535,091 +4.1% 0% $22,136,016
Penserra Capital Management LLC 1.3% 1,332,633 +15% 0.23% $19,216,000
UBS Group AG 1% 1,075,432 -8% 0% $15,507,730
Invesco Ltd. 0.89% 929,121 +43% 0% $13,397,925
WELLS FARGO & COMPANY/MN 0.71% 740,770 +9.6% 0% $10,681,902
RAYMOND JAMES FINANCIAL INC 0.41% 426,649 -40% 0% $6,152,276
ROYAL BANK OF CANADA 0.35% 366,706 -12% 0% $5,288,000
STIFEL FINANCIAL CORP 0.26% 266,580 +2.2% 0% $3,844,071
READYSTATE ASSET MANAGEMENT LP 0.24% 247,074 +665% 0.17% $3,562,807
WOLVERINE ASSET MANAGEMENT LLC 0.22% 224,518 +5782% 0.05% $3,237,549
RIVERNORTH CAPITAL MANAGEMENT, LLC 0.21% 219,276 0.18% $3,161,960
LPL Financial LLC 0.18% 186,073 -1.4% 0% $2,683,175
Shaker Financial Services, LLC 0.18% 184,069 0.91% $2,654,275
OSAIC HOLDINGS, INC. 0.15% 160,898 +12% 0% $2,309,228
Rockefeller Capital Management L.P. 0.12% 122,916 -5% 0% $1,772,455
OPPENHEIMER & CO INC 0.1% 104,131 +29% 0.02% $1,501,569
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC 0.09% 89,467 0.2% $1,290,114
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.07% 76,094 0% $1,097,275
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD 0.07% 74,070 0.08% $1,068,089
COMMONWEALTH EQUITY SERVICES, LLC 0.06% 64,462 -1% 0% $930,000
Summit Financial, LLC 0.06% 61,464 0.01% $886,314
NewEdge Advisors, LLC 0.05% 56,941 +18% 0% $821,085
BROWN, LISLE/CUMMINGS, INC. 0.04% 46,666 +3.4% 0.17% $672,921
Maridea Wealth Management LLC 0.04% 43,594 +0.73% 0.1% $653,034

Institutional Holders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 177,153 $2,681,157 +$731,631 $15.05 9
2025 Q3 10,996,937 $158,604,644 +$14,291,091 $14.42 75
2025 Q2 9,983,878 $142,327,852 -$492,482,711 $14.26 74
2025 Q1 43,195,970 $643,024,868 -$17,758,702 $14.90 98
2024 Q4 44,382,868 $639,206,490 -$2,049,010 $14.40 103
2024 Q3 44,209,630 $700,279,755 -$38,868,904 $15.84 92
2024 Q2 46,594,719 $715,544,963 +$46,363,879 $15.36 91
2024 Q1 43,338,004 $710,244,943 +$57,901,848 $16.39 98
2023 Q4 39,890,303 $584,414,772 +$128,821,399 $14.65 104
2023 Q3 31,158,319 $448,963,302 +$29,652,579 $14.41 97
2023 Q2 29,017,887 $476,511,987 +$19,029,826 $16.42 90
2023 Q1 27,645,826 $461,938,614 +$22,927,447 $16.71 83
2022 Q4 26,331,960 $406,318,059 +$55,827,669 $15.43 80
2022 Q3 22,485,082 $335,703,678 +$18,231,882 $14.93 73
2022 Q2 21,632,470 $355,409,929 +$17,938,349 $16.43 77
2022 Q1 20,259,613 $406,372,063 +$35,376,780 $20.06 67
2021 Q4 18,445,245 $467,763,272 -$14,257,983 $25.36 70
2021 Q3 18,927,398 $510,660,360 +$13,501,426 $26.98 67
2021 Q2 18,425,464 $532,844,516 +$10,813,760 $28.92 67
2021 Q1 18,116,526 $476,444,640 +$138,702,824 $26.30 64
2020 Q4 12,832,855 $367,675,522 +$42,052,163 $28.65 49
2020 Q3 11,393,980 $271,777,833 +$83,226,929 $23.85 44
2020 Q2 7,914,318 $165,566,000 +$59,116,281 $20.91 38
2020 Q1 4,878,111 $87,329,000 +$87,239,000 $17.90 20